|
|
Blood, Vol. 113, Issue 24, 6077-6084, June 11, 2009
Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study
Blood Schmiegelow et al.
113: 6077
Supplemental materials for: Schmiegelow et al
Participating pediatric departments (alphabetic order, country and city) Denmark:
Schmiegelow K, University Hospital, Rigshospitalet, Copenhagen
Hejl M, University Hospital, Odense
Østergård M, University Hospital, Ålborg
Schrøder H, University Hospital, Århus Finland:
Pihkala U, Helsinki University Hospital, Helsinki
Ilanmaa E, Kanta-Häme Central Hospital, Hämeenlinna
Antila K, Pohjois-Karjala Central Hospital, Joensuu
Korpela K, Keski-Suomi Central Hospital, Jyväskylä
Vuorinen O, Keski-Pohjanmaa Central Hospital, Kokkola
Perkkiö M, Kuopio University Hospital, Kuopio
Kojo N, Etelä-Karjala Central Hospital, Lappeenranta
Nyman R, Päijät-Häme Central Hospital, Lahti
Pere M, Mikkeli Central Hospital, Mikkeli
Lanning M, Oulu University Hospital, Oulu
Niemi A, Satakunta Central Hospital, Pori
Vuoristo A, Lappi Central Hospital, Rovaniemi
Niemi S, Kuusankoski Hospital, Kuusankoski
Isotalo J, Seinäjoki Central Hospital, Seinäjoki
Laapas H, Savonlinna Central Hospital, Savonlinna
Mäkipernaa A, Tampere University Hospital, Tampere
Salmi T, Turku University Hospital, Turku
Varsamäki T, Vaasa Central Hospital, Vaasa Iceland:
Kristinsson J, Landspitalinn, Rejkjavik Norway:
Zeller B, Municipal Hospital, Akershus
Danielsen O, Municipal Hospital, Arendal
Madsen B, University Hospital, Bergen
Nielsen B, Municipal Hospital, Bodö
Stensvold K, Municipal Hospital, Drammen
Lund JH, Municipal Hospital Frederiksstad
Danielsen K, Municipal Hospital, Kristiansand
Brekke P, Municipal Hospital, Molde
Stamnes O, Municipal Hospital, Porsgrunn
Glomstein A, Rikshospitalet, Oslo
Widing E, Ullevål Sykehus, Oslo
Hapnes C, Municipal Hospital, Stavanger
Stokland T, University Hospital, Tromsø
Kolmannskog S, University Hospital, Trondheim
Halvorsen B, Municipal Hospital, Tønsberg
Spangen S, Municipal Hospital, Ålesund Sweden:
Carlsson G, Boden Hospital, Boden
Bergkvist M, Borås Hospital, Borås
Skanka N, Eskilstuna Hospital, Eskilstuna
Korlén B, Falun Hospital, Falun
Dimberg A, Gällivare Hospital, Gällivare
Adrian B-A, Gävle Hospital, Gävle
Mellander L, Eastern Hospital, Gotenburg
Aronson S, Halmstad Hospital, Halmstad
Jensen D, Helsingborg Hospital, Helsingborg
Winiarski J, Huddinge Hospital, Huddinge
Lagerwall Å, Hudiksvall Hospital, Hudiksvall
Jonsson N-O, Jönköping Hospital, Jönköping
Cervin T, Kalmar Hospital, Kalmar
Samuelsson U, Karlskrona Hospital, Karlskrona
Berg A, Central Hospital, Karlstad
Nilsson H, Kristianstad Hospital, Kristianstad
Behrendtz M, Linköping Hospital, Linköping
Wiebe T, University Hospital, Lund
Ljung R, Malmö Hospital, Malmö
Tessin I, Möln¬dal Hospital, Mölndal
Ljungren CG, Norrköping Hospital, Norrköping
Dohlwitz A, Nyköping Hospital, Nyköping
Christensen HO, Skellefteå Hospital, Skellefteå
Ronge E, Kärnsjuk¬huset, Skövde
Berglund M, Sollefteå Hospital, Sollefteå
Björk O, Karolinska Institute, Stockholm
Fransson D, Sundsvall Hospital, Sundsvall
Eriksson M, Uddevalla Hospital, Uddevalla
Erik Forestier, University Hospital, Umeå
Kreuger A, University Hospital Uppsala
Blomgren M, Visby Hospital, Visby
Rönnblad B, Trollhättan Hospital, Trollhättan
Eriksson B, Västervik Hospital, Västervik
Berg T, Västerås Hospital, Västerås
Hedling L, Växjø Hospital, Växjø
Forsberg T, Ängelholm Hospital, Ängelhjolm
Lindquist B, Örebro Medical Center, Örebro
Kriström B, Örnsköldsvik Hospital, Örnsköldsvik
Hjalmars U, Östersund Hospital, Östersund
|
|
